XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Precipio, Inc. [Member]
Noncontrolling Interest in Joint Venture [Member]
Total
Balance at beginning of period at Dec. 31, 2020   $ 176 $ 85,523 $ (71,564) $ 14,135 $ 27 $ 14,162
Balance at beginning of period (in shares) at Dec. 31, 2020 47 17,576,916          
Increase (Decrease) in Stockholders' Equity              
Net loss       (8,530) (8,530) 13 (8,517)
Issuance of common stock in connection with purchase agreements   $ 5 1,255   1,260   1,260
Issuance of common stock in connection with purchase agreements (in shares)   500,000          
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 45 14,902   14,947   14,947
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   4,501,000          
Proceeds upon issuance of common stock from exercise of warrants   $ 1 399   400   400
Proceeds upon issuance of common stock from exercise of warrants (in shares)   74,000          
Proceeds upon issuance of common stock from exercise of stock options     3   3   3
Proceeds upon issuance of common stock from exercise of stock options (in shares)   1,379          
Write-off warrant liability in conjunction with warrant exercises     320   320   320
Issuance of common stock for consulting services     150   150   150
Issuance of common stock for consulting services (in shares)   55,147          
Stock-based compensation     1,879   1,879   1,879
Balance at end of period at Dec. 31, 2021   $ 227 104,431 (80,094) 24,564 40 24,604
Balance at end of period (in shares) at Dec. 31, 2021 47 22,708,442          
Balance at beginning of period at Dec. 31, 2020   $ 176 85,523 (71,564) 14,135 27 14,162
Balance at beginning of period (in shares) at Dec. 31, 2020 47 17,576,916          
Balance at end of period at Dec. 31, 2022   $ 228 108,371 (92,297) 16,302 65 16,367
Balance at end of period (in shares) at Dec. 31, 2022 47 22,820,260          
Balance at beginning of period at Dec. 31, 2021   $ 227 104,431 (80,094) 24,564 40 24,604
Balance at beginning of period (in shares) at Dec. 31, 2021 47 22,708,442          
Increase (Decrease) in Stockholders' Equity              
Net loss       (12,203) (12,203) 25 (12,178)
Issuance of common stock in connection with at the market offering, net of issuance costs   $ 1 128   129   129
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)   85,023          
Proceeds upon issuance of common stock from exercise of warrants     11   11   11
Proceeds upon issuance of common stock from exercise of warrants (in shares)   26,795          
Stock-based compensation     3,801   3,801   3,801
Balance at end of period at Dec. 31, 2022   $ 228 $ 108,371 $ (92,297) $ 16,302 $ 65 $ 16,367
Balance at end of period (in shares) at Dec. 31, 2022 47 22,820,260